Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer

Journal of Clinical Oncology

Volumn 27, Issue 13, 2009, Pages 2217-2224

  Allin, Kristine H ^a   Bojesen, Stig E ^a   Nordestgaard, Børge G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOMA; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OBSERVATIONAL STUDY; POPULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; COHORT ANALYSIS; MIDDLE AGED; MORTALITY; NEOPLASM; PROSPECTIVE STUDY;

ADULT; AGED; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 65549122953     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.8440     Document Type: Article

References (30)

1. Burtis CA, Ashwood ER, Bruns DE: Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (ed 4). St Louis, MO, Elsevier Saunders, 2006
2. Pepys MB, Hirschfield GM: C-reactive protein: A critical update. J Clin Invest 111:1805-1812, 2003
3. Heikkilä K, Ebrahim S, Lawlor DA: A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 61:824-833, 2007
4. Erlinger TP, Platz EA, Rifai N, et al: C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585-590, 2004 (Pubitemid 38500312)
5. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, et al: A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66:2483-2487, 2006 (Pubitemid 43294965)
6. Heikkilä K, Harris R, Lowe G, et al: Associations of circulating C-reactive protein and interleukin-6 with cancer risk: Findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 20:15-26, 2009
7. Il'yasova D, Colbert LH, Harris TB, et al: Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14:2413-2418, 2005
8. Ito Y, Suzuki K, Tamakoshi K, et al: Colorectal cancer and serum C-reactive protein levels: A casecontrol study nested in the JACC Study. J Epidemiol 15:S185-S189, 2005 (suppl 2) (Pubitemid 41410102)
9. Otani T, Iwasaki M, Sasazuki S, et al: Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev 15:690-695, 2006
10. Rifai N, Buring JE, Lee IM, et al: Is C-reactive protein specific for vascular disease in women? Ann Intern Med 136:529-533, 2002
11. Siemes C, Visser LE, Coebergh JW, et al: C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: The Rotterdam Study. J Clin Oncol 24:5216-5222, 2006 (Pubitemid 46631365)
12. Suzuki K, Ito Y, Wakai K, et al: Serum heat shock protein 70 levels and lung cancer risk: A case-control study nested in a large cohort study. Cancer Epidemiol Biomarkers Prev 15:1733-1737, 2006 (Pubitemid 44497111)
13. Trichopoulos D, Psaltopoulou T, Orfanos P, et al: Plasma C-reactive protein and risk of cancer: A prospective study from Greece. Cancer Epidemiol Biomarkers Prev 15:381-384, 2006 (Pubitemid 43348407)
14. Tsilidis KK, Branchini C, Guallar E, et al: C-reactive protein and colorectal cancer risk: A systematic review of prospective studies. Int J Cancer 123:1133-1140, 2008
15. Zhang SM, Buring JE, Lee IM, et al: C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 142:425-432, 2005
16. Zhang SM, Lin J, Cook NR, et al: C-reactive protein and risk of breast cancer. J Natl Cancer Inst 99:890-894, 2007 (Pubitemid 47073511)
17. Clarke R, Shipley M, Lewington S, et al: Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150:341-353, 1999 (Pubitemid 29383482)
18. Al Murri AM, Bartlett JM, Canney PA, et al: Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94:227-230, 2006 (Pubitemid 43151540)
19. Heikkilä K, Ebrahim S, Rumley A, et al: Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: Findings from the British Women's Heart and Health Study. Cancer Epidemiol Biomarkers Prev 16:1155-1159, 2007 (Pubitemid 46984952)
20. McMillan DC, Elahi MM, Sattar N, et al: Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 41:64-69, 2001 (Pubitemid 34666222)
21. Nielsen HJ, Christensen IJ, Sorensen S, et al: Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol 7:617-623, 2000 (Pubitemid 30708485)
22. Scott HR, McMillan DC, Forrest LM, et al: The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87: 264-267, 2002
23. Nordestgaard BG, Benn M, Schnohr P, et al: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298:299-308, 2007 (Pubitemid 47080484)
24. Schnohr P, Jensen JS, Scharling H, et al: Coronary heart disease risk factors ranked by importance for the individual and community: A 21 year follow-up of 12000 men and women from The Copenhagen City Heart Study. Eur Heart J 23:620-626, 2002 (Pubitemid 35204246)
25. Storm HH: The Danish Cancer Registry, a self-reporting national cancer registration system with elements of active data collection. IARC Sci Publ 220-236, 1991
26. Storm HH, Michelsen EV, Clemmensen IH, et al: The Danish Cancer Registry: History, content, quality and use. Dan Med Bull 44:535-539, 1997
27. Storm HH: Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol 17:44-49, 1988
28. Coussens LM, Werb Z: Inflammation and cancer. Nature 420:860-867, 2002
29. Balkwill F, Mantovani A: Inflammation and cancer: Back to Virchow? Lancet 357:539-545, 2001
30. Engels EA: Inflammation in the development of lung cancer: Epidemiological evidence. Expert Rev Anticancer Ther 8:605-615, 2008 (Pubitemid 351818355)